Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211
Intratumoral Injection in Patients with Malignant Solid Tumors